Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC10056(±)-Myristoylcarnitine chlorideCAS: 14919-38-1
cholinergic agonist; important intermediates in lipid metabolism
- GC11079C6 Ceramide (d18:1/6:0)CAS: 124753-97-5纯度: >98.00%
C6 Ceramide (d18:1/6:0)是一种短链的、细胞可透过的神经酰胺类似物，在临床前研究中用于模拟内源性神经酰胺的作用。
- GC11894BMS 309403CAS: 300657-03-8纯度: >99.50% / >98.00%
BMS 309403是一种强效、具有口服活性且选择性的adipocyte fatty acid binding protein (FABP4)抑制剂，IC 50 值为0.71μM。
- GC13909(±)-Octanoylcarnitine chlorideCAS: 18822-86-1
(±)-Octanoylcarnitine chloride是Octanoylcarnitine的氯盐形式。
- GC14406(±)-Acetylcarnitine chlorideCAS: 2504-11-2纯度: >98.00%
weak cholinergic agonist; intermediates in lipid metabolism
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GA20357 | 1,2-Dimyristoyl-rac-glycerol | 20255-94-1 | >98.00% | |
A diacylglycerol | ||||
| GA20365 | 1,2-O-Dihexadecyl-sn-glycerol | 67337-03-5 | - | |
A long-chain DAG mimic | ||||
| GA20385 | 1-Palmitoyl-rac-glycerol | 542-44-9 | >99.00% | |
A monoacylglycerol | ||||
| GA23211 | Myristoyl-Gly-OH | 14246-55-0 | >97.00% | |
A lipidated amino acid | ||||
| GC10056 | (±)-Myristoylcarnitine chloride | 14919-38-1 | - | |
cholinergic agonist; important intermediates in lipid metabolism | ||||
| GC10203 | 1,2-Dioleoyl-sn-glycerol | 24529-88-2 | >95.00% | |
An analog of DAG | ||||
| GC10883 | Stearamide | 124-26-5 | - | |
A primary fatty acid amide | ||||
| GC11000 | Eicosapentaenoyl PAF C-16 | 132196-28-2 | >98.00% | |
A PAF analog that contains EPA | ||||
| GC11055 | 10-Pyrene-PC | 95864-17-8 | - | |
A substrate for some PLA 2 s | ||||
| GC11079 | C6 Ceramide (d18:1/6:0) | 124753-97-5 | >98.00% | |
C6 Ceramide (d18:1/6:0)是一种短链的、细胞可透过的神经酰胺类似物，在临床前研究中用于模拟内源性神经酰胺的作用。 | ||||
| GC11080 | ICI 192,605 | 117621-64-4 | - | |
A TP receptor antagonist | ||||
| GC11894 | BMS 309403 | 300657-03-8 | >99.50% / >98.00% | |
BMS 309403是一种强效、具有口服活性且选择性的adipocyte fatty acid binding protein (FABP4)抑制剂，IC 50 值为0.71μM。 | ||||
| GC12431 | RSL3 | 1219810-16-8 | >98.00% | |
RSL3被认为是一种强效的诱导铁死亡剂，其作用依赖于GPX4的活性。 | ||||
| GC12604 | Fumonisin B1 | 116355-83-0 | >98.00% / >95.00% | |
A mycotoxin | ||||
| GC13772 | SC 26196 | 218136-59-5 | >98.00% | |
SC 26196是一种具有口服活性的Delta6去饱和酶（D6D, FADS2）抑制剂，SC 26196可抑制亚油酸和α-亚麻酸向长链不饱和脂肪酸的转化以调控脂质代谢。 | ||||
| GC13880 | GPBAR-A | 877052-79-4 | - | |
agonist of bile acid receptor GPBAR1 | ||||
| GC13909 | (±)-Octanoylcarnitine chloride | 18822-86-1 | - | |
(±)-Octanoylcarnitine chloride是Octanoylcarnitine的氯盐形式。 | ||||
| GC14244 | CAY10499 | 359714-55-9 | >98.00% | |
A non-selective lipase inhibitor | ||||
| GC14278 | Myriocin | 35891-70-4 | >95.00% | |
A potent serine palmitoyltransferase inhibitor | ||||
| GC14406 | (±)-Acetylcarnitine chloride | 2504-11-2 | >98.00% | |
weak cholinergic agonist; intermediates in lipid metabolism | ||||
| GC14583 | R 59-022 | 93076-89-2 | 不显示 | |
R 59-022是一种二酰甘油激酶抑制剂（IC 50 = 2.8µM）。 | ||||
| GC15834 | (±)-Decanoylcarnitine chloride | 14919-36-9 | >98.00% | |
脂质代谢中间体 | ||||
| GC15993 | Lauric Acid | 143-07-7 | >98.00% | |
A medium-chain fatty acid | ||||
| GC16427 | (±)-Lauroylcarnitine chloride | 7023-03-2 | - | |
important intermediates in lipid metabolism | ||||